Day: November 18, 2020

Investor Presentation Accessible on the Company’s Investor Relations WebsiteLAS VEGAS, Nov. 18, 2020 (GLOBE NEWSWIRE) — Marathon Patent Group, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), one of the largest publicly traded Bitcoin self-mining company in North America, has unveiled a new investor presentation, which contains updated financial information as of November 5, 2020. The presentation can be accessed on the Company’s website here.The presentation’s highlights, which are based on Bitcoin’s seven day average price as of November 17th of approximately $16,000 and the network’s difficulty rating in mid-November, include, but are not limited to the following:Strong balance sheet with $24.6 million in cash and no debtOverview of exclusive partnerships with Beowulf and Bitmain that provide low energy costs...

BRIDGEWATER, N.J., Nov. 18, 2020 (GLOBE NEWSWIRE) — RVL Pharmaceuticals, Inc., a subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica”), announced the addition of Dr. Raymond Douglas, M.D. to its leadership team as Global Head, Scientific Affairs.“We are thrilled to have Dr. Douglas join our organization and are committed to building upon the recent launch success of Upneeq. Dr. Douglas will immediately become an integral member of the organization,” said Brian Markison, Chief Executive Officer of Osmotica. “His clinical training in ophthalmology, and surgical and cosmetic expertise in practice, will undoubtedly further support our strategic initiatives as we expand the launch of Upneeq.”Dr. Douglas is a board-certified Aesthetic Reconstructive and Oculoplastic specialist. His expertise has made him a highly...

HOUSTON, Texas, Nov. 18, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — CHNC (OTCPK: CHNC) Phytotherapy therapeutic program, comprised of cannabinoid molecule formulations, has the advantage of not having adverse effects and was developed to treat each of the three stages of COVID-19; from moderate, to the critical curse, and for the final leg of persistent inflammation, immunosuppression and catabolism syndrome.Faced with the race and struggle of pharmaceutical companies around the world to find a vaccine, Pharmacology University, an educational cannabis firm and Precision Research Institute, both owned and operated by CHNC an OTC publicly traded company under the symbol CHNC, have investigated the palliative benefits that cannabinoids can have in treating the effects of COVID-19 (SARS-CoV-2), thus, obtaining a hortus siccus medicinal...

BEVERLY, Mass. and TORONTO, Nov. 18, 2020 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that management will participate in the Piper Sandler 32nd Annual Healthcare Conference on Tuesday to Thursday, December 1-3, 2020. David Wolf, President and CEO of Hamilton Thorne Ltd., will provide a pre-recorded investor presentation and will be available for virtual one-on-one meetings during the conference. To schedule a meeting with management, please contact your conference representative or email ir@hamiltonthorne.ltd.About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)Hamilton Thorne is a leading global provider of precision instruments, consumables,...

TAMPA, FL, Nov. 18, 2020 (GLOBE NEWSWIRE) — Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the Diamond Equity Research Emerging Growth Invitational investor conference taking place virtually on December 1, 2020.Suren Ajjarapu, Chief Executive Officer of TRxADE Group, is scheduled to host a virtual presentation to investors, followed by a guided question and answer session as follows:Diamond Equity Research Emerging Growth InvitationalDate: December 1, 2020Time: 3:40 p.m. Eastern timeWebcast: https://us02web.zoom.us/webinar/register/WN_mkLm5d7kQPiVt3p7Eipy_AA live audio webcast and a 90-day archived replay of the conference presentation will be available using the webcast link above. For more information on the Diamond Equity Research Emerging...

Singapore – 17 November 2020 – Propine, Singapore’s first independent and regulated digital asset custodian, has entered into a strategic partnership with Skyhook Capital, the Singapore based fintech SaaS platform that provides institutional investors access to digital securities seamlessly incorporated within their traditional wealth portfolio’s. The partnership between Propine and Skyhook Capital will better serve institutional investors in storing their digital assets securely through a fully compliant custody service, with layered governance and security practices built in for safe maintenance and delivery. Under the agreement, Propine will extend its digital custodial and lifecycle management and reporting services to Skyhook Capital’s end customers whose assets will remain in custody. In addition, Propine will support issuers with...